Moreover, higher expression of MAD2L2 was associated with lower tumor volume, earlier TNM stage, less invasion, and a smaller chance of distant metastasis in CRC patients (Table 2), which suggested that MAD2L2 was a suppressor of CRC growth and metastasis. The gene discussed is MAD2L2; the disease is neoplasm.